Previous 10 | Next 10 |
Clinical Value of MRIdian® MRI-Guided Radiation Therapy in the Treatment of Ultracentral/Central Lung Tumors Presented at ESTRO 2022 PR Newswire Retrospective analysis shows MRIdian's small treatment margins enabled by adaptation and real-time tracking and automat...
The following slide deck was published by ViewRay, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: ViewRay, Inc. 2022 Q1 - Results - Earnings Call Presentation
ViewRay, Inc. (VRAY) Q1 2022 Earnings Conference Call May 5, 2022, 4:30 PM ET Company Participants Matt Harrison - Director, Investor Relations Scott Drake - President and CEO Zach Stassen - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Frank Pinal - Jeffer...
Image source: The Motley Fool. ViewRay, Inc. (NASDAQ: VRAY) Q1 2022 Earnings Call May 05, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: ViewRay, Inc. (VRAY) Q1 2022 Earnings Call Transcript
MRIdian Clinical and Research Experience Featured in Nearly 40 Abstracts at ESTRO 2022, the Leading European Radiation Oncology Meeting PR Newswire ViewRay celebrates 10-years as the first and only company to offer real-time tissue tracking with automatic beam gating a...
Gainers: iRhythm Technologies (IRTC) +30%. Funko (FNKO) +26%. Opendoor Technologies (OPEN) +15%. Alphatec Holdings (ATEC) +14%. ViewRay. (VRAY) +12%. Losers: frontdoor (FTDR) -26%. Leslie's (LESL) -13%. Zillow Group (ZG) -11%. Luminar Te...
ViewRay press release (NASDAQ:VRAY): Q1 GAAP EPS of -$0.14 beats by $0.02. Revenue of $18.9M (+21.7% Y/Y) beats by $3.28M. For further details see: ViewRay GAAP EPS of -$0.14 beats by $0.02, revenue of $18.9M beats by $3.28M
ViewRay Announces First Quarter 2022 Results PR Newswire CLEVELAND , May 5, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the first quarter ended March 31, 2022 . First Quarter 2022 Highl...
UCI Health Adopts ViewRay® MRIdian® MRI-Guided Radiation Therapy System PR Newswire MRIdian will be the First MRI-Guided Radiation Therapy System at the UCI Chao Family Comprehensive Cancer Center facility opening in late 2023 CLEVELAND , Ma...
Kahn Brothers’ 13F portfolio value increased from $741M to $788M this quarter. Citigroup, ViewRay, and VOXX International were increased during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~48% of the 13F holdings. ...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...